BENJAMIN F. EDWARDS & COMPANY, INC. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
BENJAMIN F. EDWARDS & COMPANY, INC. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$6,000
+20.0%
1000.0%0.00%
Q2 2022$5,000
-66.7%
100
-50.0%
0.00%
-100.0%
Q1 2022$15,000
-37.5%
2000.0%0.00%0.0%
Q4 2021$24,000
+118.2%
200
-63.6%
0.00%0.0%
Q3 2020$11,000
-8.3%
5500.0%0.00%0.0%
Q2 2020$12,000
+71.4%
5500.0%0.00%0.0%
Q1 2020$7,000
-12.5%
5500.0%0.00%0.0%
Q4 2019$8,000
+14.3%
5500.0%0.00%0.0%
Q3 2019$7,000
-85.1%
550
-81.0%
0.00%
-75.0%
Q2 2019$47,000
-6.0%
2,8990.0%0.00%
-20.0%
Q1 2019$50,000
+61.3%
2,899
+26.1%
0.01%
+66.7%
Q4 2018$31,000
-53.0%
2,2990.0%0.00%
-50.0%
Q3 2018$66,000
+4.8%
2,2990.0%0.01%0.0%
Q2 2018$63,000
+53.7%
2,299
+17.4%
0.01%
+50.0%
Q1 2018$41,000
+64.0%
1,958
+52.1%
0.00%
+33.3%
Q4 2017$25,000
+19.0%
1,287
+49.3%
0.00%0.0%
Q3 2017$21,000
+50.0%
8620.0%0.00%
+50.0%
Q2 2017$14,000
+75.0%
862
+56.7%
0.00%
+100.0%
Q1 2017$8,000
+14.3%
5500.0%0.00%0.0%
Q4 2016$7,000
-22.2%
5500.0%0.00%
-50.0%
Q3 2016$9,0005500.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders